Pelthos Therapeutics Inc. (PTHS) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -13.13M | -6.25M | -15.26M | -447.14K | -632.13K | -670.26K | -177.91K | -2.95M | -1.99M | -356.81K |
| Operating CF Margin % | -120.36% | -66.59% | -206.03% | - | - | - | - | - | - | - |
| Operating CF Growth % | -1976.48% | -832.77% | -8476.61% | 84.85% | 68.27% | -87.85% | - | - | - | - |
| Net Income | -10.24M | -21.66M | -16.24M | -3.45M | -1.97M | -1.93M | -1.69M | -1.77M | -2.56M | -4.04M |
| Depreciation & Amortization | 1.57M | 1.22M | 1.14M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 413.49K | 485.83K | 530.42K | 517.34K | 458.98K | 292.55K | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -2.02M | 18.41M | 4.87M | 164.68K | 94.21K | 76.09K | -352.79K | 0 | 605.63K | 3.14M |
| Working Capital Changes | -2.44M | -4.22M | -5.03M | 2.42M | 755.44K | 649.96K | 1.35M | -1.64M | -327.75K | 544.04K |
| Change in Receivables | -2.84M | -870K | -7.94M | 0 | 0 | 0 | 0 | 0 | -45.79K | 0 |
| Change in Inventory | 156K | 393K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 3.16M | -2.67M | 928.52K | 2.4M | 706.48K | 620.98K | 2.04M | -1.57M | 90.99K | 460.13K |
| Cash from Investing | -194K | -8M | 2.76M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | -194K | -99K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | 1.78% | 1.05% | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | -7.9M | 2.76M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 27.52M | 18.02M | 26.69M | 375K | 250K | -71.2K | -972.28K | 1.59M | 5.67M | 430.41K |
| Debt Issued (Net) | 27.52M | 17.9M | -777K | 375K | 250K | -153.82K | -897.28K | 1.59M | -214.76K | 175K |
| Equity Issued (Net) | 0 | 121K | 27.47M | 0 | 0 | 82.62K | -75K | 0 | 5.88M | 255.41K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | -75K | 0 | -91.51K | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 14.2M | 3.77M | 14.12M | -72.14K | -382.13K | -741.46K | -1.15M | -1.37M | 3.67M | 73.61K |
| Free Cash Flow | -13.32M | -6.35M | -15.26M | -447.14K | -632.13K | -670.26K | -177.91K | -2.95M | -1.99M | -356.81K |
| FCF Margin % | -122.13% | -67.64% | -206.03% | - | - | - | - | - | - | - |
| FCF Growth % | -2007.17% | -847.54% | -8476.61% | 84.85% | 68.27% | -87.85% | - | - | - | - |
| FCF per Share | -4.02 | -2.01 | -23.82 | -0.70 | -1.03 | -1.12 | -0.31 | -5.11 | -4.25 | -0.61 |
| FCF Conversion (FCF/Net Income) | 1.28x | 0.29x | 0.94x | 0.13x | 0.32x | 0.35x | 0.10x | 1.67x | 0.78x | 0.09x |
| Interest Paid | 0 | 0 | 0 | 7.5K | 11.25K | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |